SurModics (NASDAQ: SRDX) reported Q2 EPS of $0.20, $0.11 better than the analyst estimate of $0.09. Revenue for the quarter came in at $16.7 million versus the consensus estimate of $15.13 million.

SurModics reaffirmed FY2016 guidance.

For earnings history and earnings-related data on SurModics (SRDX) click here.